Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company develop...
Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for cancer and autoimmune diseases,...
Author: statnews.com
Read Original Article